2015年
- Category：業績
≪英文≫
Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
Saito Y, Ohnishi K, Miyashita A, Nakahara S, Fujiwara Y, Horlad H, Motoshima T, Fukushima S, Jinnin M, Ihn H, Takeya M, Komohara Y.
Cancer Immunol Res. 2015 Dec;3(12):1356-63.
Ito N, Kojima S, Teramukai S, Mikami Y, Ogawa O, Kamba T.
Int J Clin Oncol. 2015 Dec;20(6):1161-70.
Eto M, Kawano Y, Hirao Y, Mita K, Arai Y, Tsukamoto T, Hashine K, Matsubara A, Fujioka T, Kimura G, Shinohara N, Tatsugami K, Hinotsu S, Naito S; Japan RCC Trialist Collaborative Group (JRTCG) investigators.
BMC Cancer. 2015 Oct 9;15:667.
Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer.
Nozawa M, Mukai H, Takahashi S, Uemura H, Kosaka T, Onozawa Y, Miyazaki J, Suzuki K, Okihara K, Arai Y, Kamba T, Kato M, Nakai Y, Furuse H, Kume H, Ide H, Kitamura H, Yokomizo A, Kimura T, Tomita Y, Ohno K, Kakehi Y.
Int J Clin Oncol. 2015 Oct;20(5):1026-34.
Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
Shibasaki N, Yamasaki T, Kanno T, Arakaki R, Sakamoto H, Utsunomiya N, Inoue T, Tsuruyama T, Nakamura E, Ogawa O, Kamba T.
PLoS One. 2015 Jun 26;10(6):e0130980.
Motoshima T, Komohara Y, Horlad H, Takeuchi A, Maeda Y, Tanoue K, Kawano Y, Harada M, Takeya M, Eto M.
Oncol Rep. 2015 Jun;33(6):2947-53.
Shinohara N, Obara W, Tatsugami K, Naito S, Kamba T, Takahashi M, Murai S, Abe T, Oba K, Naito S.
Cancer Sci. 2015 May;106(5):618-26.
Maeda Y, Kawano Y, Wada Y, Yatsuda J, Motoshima T, Murakami Y, Kikuchi K, Imamura T, Eto M.
Oncol Rep. 2015 Apr;33(4):1844-50.